Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors

This study has been terminated.
(Sponsor's decision)
Sponsor:
Collaborator:
Westat
Information provided by (Responsible Party):
Albany Molecular Research, Inc.
ClinicalTrials.gov Identifier:
NCT00724100
First received: July 25, 2008
Last updated: August 26, 2014
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)